Literature DB >> 8867068

Magnetic resonance imaging and spectroscopy of progressive cerebral involvement in Kearns Sayre Syndrome.

P Kapeller1, F Fazekas, H Offenbacher, R Stollberger, R Schmidt, J Berglöff, H Radner, G Fazekas, I Schafhalter-Zoppoth.   

Abstract

Kearns Sayre Syndrome (KSS) belongs to the group of so called 'mitochondrial encephalopathies'. Magnetic resonance imaging (MRI) and magnetic resonance spectroscopy (MRS) may have the potential to noninvasively detect and monitor disease specific cerebral involvement, as we wish to demonstrate in a patient whom we have followed for 3.5 years. At first presentation with incomplete external ophthalmoplegia, ptosis, pigmentary retinopathy and impaired hearing MRI demonstrated ill defined areas of symmetric T2-prolongation in the dorsal parts of the mesencephalon, the pons and in both cerebellar hemispheres. While the patients clinical symptoms deteriorated, including the onset of dysphagia, signal abnormalities spread downwards into the medulla oblongata involving the glossopharyngeal nuclei and supratentorially into the white matter. Proton MRS performed with the PRESS sequence (TR/TE 1500/136 ms) in the area of white matter damage showed a doublet at 1.33 ppm, which is characteristic for the presence of lactate. Our findings suggest MRI abnormalities to increase in parallel with neurologic progression of KSS and confirm the utility of 1H-MRS in supporting mitochondrial respiratory chain insufficiency as the underlying cause of parenchymal alterations.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8867068     DOI: 10.1016/0022-510x(95)00290-i

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN: 0022-510X            Impact factor:   3.181


  11 in total

Review 1.  Inborn errors of metabolism for the diagnostic radiologist.

Authors:  Chris J Hendriksz
Journal:  Pediatr Radiol       Date:  2008-12-13

2.  Proton magnetic resonance spectroscopy and MRI reveal no evidence for brain mitochondrial dysfunction in children with autism spectrum disorder.

Authors:  Neva M Corrigan; Dennis W W Shaw; Todd L Richards; Annette M Estes; Seth D Friedman; Helen Petropoulos; Alan A Artru; Stephen R Dager
Journal:  J Autism Dev Disord       Date:  2012-01

Review 3.  In Vivo NMR Studies of the Brain with Hereditary or Acquired Metabolic Disorders.

Authors:  Erica B Sherry; Phil Lee; In-Young Choi
Journal:  Neurochem Res       Date:  2015-11-26       Impact factor: 3.996

Review 4.  Adult-onset leukodystrophies from respiratory chain disorders: do they exist?

Authors:  Ettore Salsano; Laura Farina; Costanza Lamperti; Giuseppe Piscosquito; Franco Salerno; Lucia Morandi; Franco Carrara; Eleonora Lamantea; Massimo Zeviani; Graziella Uziel; Mario Savoiardo; Davide Pareyson
Journal:  J Neurol       Date:  2013-01-29       Impact factor: 4.849

Review 5.  Neuroimaging of mitochondrial disease.

Authors:  Russell P Saneto; Seth D Friedman; Dennis W W Shaw
Journal:  Mitochondrion       Date:  2008-05-23       Impact factor: 4.160

6.  Follow-up of folinic acid supplementation for patients with cerebral folate deficiency and Kearns-Sayre syndrome.

Authors:  Pilar Quijada-Fraile; Mar O'Callaghan; Elena Martín-Hernández; Raquel Montero; Àngels Garcia-Cazorla; Ana Martínez de Aragón; Jordi Muchart; Ignacio Málaga; Rafael Pardo; Pedro García-Gonzalez; Cristina Jou; Julio Montoya; Sonia Emperador; Eduardo Ruiz-Pesini; Joaquín Arenas; Miguel Angel Martin; Aida Ormazabal; Mercè Pineda; María T García-Silva; Rafael Artuch
Journal:  Orphanet J Rare Dis       Date:  2014-12-24       Impact factor: 4.123

Review 7.  Gastrointestinal manifestations of mitochondrial disorders: a systematic review.

Authors:  Josef Finsterer; Marlies Frank
Journal:  Therap Adv Gastroenterol       Date:  2016-10-06       Impact factor: 4.409

8.  Diagnostic value of MRS-quantified brain tissue lactate level in identifying children with mitochondrial disorders.

Authors:  Roelineke J Lunsing; Kim Strating; Tom J de Koning; Paul E Sijens
Journal:  Eur Radiol       Date:  2016-06-07       Impact factor: 5.315

9.  Proton MR spectroscopy of mitochondrial diseases: analysis of brain metabolic abnormalities and their possible diagnostic relevance.

Authors:  M Cristina Bianchi; Michela Tosetti; Roberta Battini; Maria L Manca; Michelangelo Mancuso; Giovanni Cioni; Raffaello Canapicchi; Gabriele Siciliano
Journal:  AJNR Am J Neuroradiol       Date:  2003 Nov-Dec       Impact factor: 3.825

10.  Extraocular muscle atrophy and central nervous system involvement in chronic progressive external ophthalmoplegia.

Authors:  Cynthia Yu-Wai-Man; Fiona E Smith; Michael J Firbank; Grant Guthrie; Stuart Guthrie; Grainne S Gorman; Robert W Taylor; Douglass M Turnbull; Philip G Griffiths; Andrew M Blamire; Patrick F Chinnery; Patrick Yu-Wai-Man
Journal:  PLoS One       Date:  2013-09-27       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.